Merck KGaA’s $1.1B Silence Therapeutics Buyout Brings RNA Drug for Rare Blood Cancer
The Silence Therapeutics acquisition provides Merck KGaA a drug prepared for a pivotal check within the blood dysfunction polycythemia vera. ...
Tag: Therapeutics
City Therapeutics’ Upsized IPO Raises $200M to Bring RNAi Drugs Beyond the Liver
Metropolis Therapeutics’ lead RNA interference remedy may change into an alternative choice to blockbuster-selling anticoagulants. The corporate’s expertise for designing ...
CRISPR Biotech Scribe Therapeutics Writes a New Chapter With $129M IPO
Scribe Therapeutics’ IPO will help a pipeline led by a genetic drugs that represses expression of its goal gene with ...
FDA approves Vera Therapeutics kidney disease treatment
Adam Feuerstein is a senior author and biotech columnist, reporting on the crossroads of drug growth, enterprise, Wall Road, and ...
Enliven Therapeutics’ leukemia drug shows promise in new study
Adam Feuerstein is a senior author and biotech columnist, reporting on the crossroads of drug growth, enterprise, Wall Avenue, and ...
Servier Moves Into Muscular Dystrophy, Paying $1.5B for Assets From Edgewise Therapeutics
France-based pharma firm Servier is buying the muscular dystrophy enterprise of Edgewise Therapeutics as a part of a income progress ...
Under FDA Clinical Hold, Aardvark Therapeutics Seeks Path Forward for Metabolic Drug
The total FDA scientific maintain formally halts all exams of Aardvark Therapeutics’ drug for Prader-Willi syndrome, a uncommon inherited metabolic ...
Structure Therapeutics Oral GLP-1 Obesity Drug Achieves ‘Injectable-Like Efficacy’ in Phase 2 Test
Construction Therapeutics’ aleniglipron, a once-daily oral GLP-1 drug, led to a mean 16% weight reduction measured at 44 weeks. Primarily ...
Is Aldeyra Therapeutics waving red flags with consequences?
Adam Feuerstein is a senior author and biotech columnist, reporting on the crossroads of drug growth, enterprise, Wall Road, and ...
Candid Therapeutics Strikes Up Merger With Rallybio to Advance Its Autoimmune Drug Pipeline
Together with the reverse merger, Candid Therapeutics introduced $505 million in non-public financing to help its pipeline of T cell ...
Discover the latest in health and fitness with Your Health 247. Get expert advice, workout routines, healthy recipes, and mental wellness tips to lead a healthier, happier life. Stay informed and empowered with us!